Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

4.0K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.0K
Necrosis01:16

Necrosis

5.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clopidogrel versus ticagrelor in dual antiplatelet therapy for flow diversion of unruptured intracranial aneurysms: analysis of the Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) Cerebral Aneurysm Registry.

Journal of neurointerventional surgery·2026
Same author

Oncofetal RNA-binding proteins of IGF2BP family suppress IRF-3 and NF-kB dependent transcription downstream of cytosolic RNA sensors.

bioRxiv : the preprint server for biology·2026
Same author

Clinical Outcome of EMG-Based Pelvic Floor Biofeedback in Patients With Constipation-Impact of Prior Anorectal Manometry/Balloon Expulsion Test for Patient Selection. A Retrospective Study.

Neurogastroenterology and motility·2026
Same author

ASO Visual Abstract: Efficacy of Adjuvant Chemoimmunotherapy Versus Chemotherapy and the Impact of Lymph Node Dissection on Survival.

Annals of surgical oncology·2026
Same author

L-DOPA influences transferrin-dependent iron release at the blood-brain barrier.

Fluids and barriers of the CNS·2026
Same author

Efficacy of Adjuvant Chemoimmunotherapy versus Chemotherapy and the Impact of Lymph Node Dissection on Survival.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Nov 3, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

663

Association Between Iron and Cholesterol in Neuroblastomas.

Sang Y Lee1, Becky Slagle-Webb2, Cara-Lynne Schengrund3

  • 1Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, PA, U.S.A.; lsysys627@gmail.com.

Anticancer Research
|June 4, 2021
PubMed
Summary

This study explored the relationship between iron and cholesterol in neuroblastoma, finding that cholesterol-lowering drugs may be more effective than iron chelators for treating drug-resistant neuroblastoma.

Keywords:
Deferoxaminedrug-resistanceiron chelatorsimvastatin

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

629
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.4K

Related Experiment Videos

Last Updated: Nov 3, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

663
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

629
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.4K

Area of Science:

  • Oncology
  • Biochemistry
  • Cell Biology

Background:

  • Neuroblastoma is a common childhood cancer.
  • Iron and lipids are essential for cancer cell division.
  • The interplay between iron and lipid metabolism in neuroblastoma remains unexamined.

Purpose of the Study:

  • To investigate the association between iron and cholesterol levels in neuroblastoma.
  • To explore the impact of iron and cholesterol modulation on neuroblastoma cell lines.

Main Methods:

  • In vitro evaluation of iron and cholesterol levels in neuroblastoma models.
  • Assessment of the bidirectional association between iron and cholesterol.
  • Treatment of drug-resistant neuroblastoma cells with an iron chelator and simvastatin.

Main Results:

  • Neuroblastoma cell lines exhibit varied iron and cholesterol levels.
  • A bidirectional relationship between iron and cholesterol was observed in drug-resistant SK-N-AS cells.
  • An iron chelator affected cholesterol levels, while simvastatin impacted both iron and cholesterol levels in drug-resistant cells.

Conclusions:

  • Cholesterol modulation may offer a more promising therapeutic strategy than iron chelation for drug-resistant neuroblastoma.
  • Targeting cholesterol metabolism could be a novel approach for neuroblastoma treatment.